Demonstration of an online tool to assist managed care formulary evidence-based decision making: meta-analysis of topical prostaglandin analog efficacy

by Kymes, Steven M, Burk, Caroline, Feinman, Todd, Williams, Julia M, Hollander, David A
Published 2011

Primary graft failure associated with epithelial downgrowth: a case report

by Aldave, Anthony J, Hollander, David A, Branco, Bruno, Crawford, Brooks, Abbott, Richard L
Published 2005

Ex vivo corneal epithelial wound healing following exposure to ophthalmic nonsteroidal anti-inflammatory drugs

by Xu, Keping, McDermott, Mark, Villanueva, Linda, Schiffman, Rhett M, Hollander, David A
Published 2011

PERSIST: Physician’s Evaluation of Restasis® Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review

by Mah, Francis, Milner, Mark, Yiu, Samuel, Donnenfeld, Eric, Conway, Taryn M, Hollander, David A
Published 2012

Inflammation in Retinal Disease

by Whitcup, Scott M., Nussenblatt, Robert B., Lightman, Susan L., Hollander, David A.
Published 2013

A multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model

by Ackerman, Stacey, D’Ambrosio, Francis, Greiner, Jack V, Villanueva, Linda, Ciolino, Joseph B, Hollander, David A
Published 2013

Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials

by Myers, Jonathan S, Vold, Steven, Zaman, Fiaz, Williams, Julia M, Hollander, David A
Published 2014

Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients

by Stonecipher, Karl G, Chia, Jenny, Onyenwenyi, Ahunna, Villanueva, Linda, Hollander, David A
Published 2013

The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye

by Stonecipher, Karl G, Torkildsen, Gail L, Ousler, George W, Morris, Scot, Villanueva, Linda, Hollander, David A
Published 2016

Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost

by Fechtner, Robert D, Harasymowycz, Paul, Nixon, Donald R, Vold, Steven D, Zaman, Fiaz, Williams, Julia M, Hollander, David A
Published 2011

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits: response to authors

by Chang-Lin, Joan-En, Batoosingh, Amy L, Hollander, David A, Schiffman, Rhett M, Tang-Liu, Diane D-S
Published 2011

Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review stud...

by Dugel, Pravin U., Capone, Antonio, Singer, Michael A., Dreyer, Richard F., Dodwell, David G., Roth, Daniel B., Shi, Rui, Walt, John G., Scott, Lanita C., Hollander, David A.
Published 2015

Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials

by Ciolino, Joseph B, McLaurin, Eugene B, Marsico, Nicholas P, Ackerman, Stacey L, Williams, Julia M, Villanueva, Linda, Hollander, David A
Published 2015

Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials

by McLaurin, Eugene B., Marsico, Nicholas P., Ackerman, Stacey L., Ciolino, Joseph B., Williams, Julia M., Villanueva, Linda, Hollander, David A.
Published 2014

Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart rev...

by Singer, Michael A, Capone Jr, Antonio, Dugel, Pravin U, Dreyer, Richard F, Dodwell, David G, Roth, Daniel B, Shi, Rui, Walt, John G, Scott, Lanita C, Hollander, David A
Published 2015